Spero Therapeutics (SPRO) Q3 2023 Earnings

13NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.34
-0.04
0.25
0.55

Details

Expected EPS
-0.03
Actual EPS
-0.06
Surprise EPS
-0.03
Surprise Percent
+100%

Description

Spero Therapeutics (SPRO) has reported earnings of -0.06 per share for Q3 2023.

0 Comments

Share your thoughts